Neuroscience genomics Group 14 by francisca trigo

franciscatrigo10 — 2024-04-05 11:21:16 UTC

Antónia Chiara Terracciano 117698

Diana Pontinha 118415

Francisca Trigó 118464

Noemi Scala 117923

franciscatrigo10 — 2024-04-05 14:08:19 UTC

franciscatrigo10 — 2024-04-05 14:10:08 UTC

Somatic genomic changes in single Alzheimer’s disease neurons 2022

franciscatrigo10 — 2024-05-06 10:34:15 UTC

Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease

franciscatrigo10 — 2024-05-06 10:35:06 UTC

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

franciscatrigo10 — 2024-05-06 10:35:58 UTC

Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses

franciscatrigo10 — 2024-05-06 10:37:33 UTC

Pros and Cons to choose this article

franciscatrigo10 — 2024-05-06 10:38:57 UTC

Pros - All five points. European project and Million Veteran Program. Many financiers, and consortia.

Very clear objective on a social level: “Our findings have potential clinically relevant applications” and ethically approved.

Methods and software explained and with reference links. Very detailed but organized and understandable. Lots of data from everywhere.

Interesting topic of genetic basis of depression even in comorbidity.

Cons - Very long.

In the final part some data must be requested because it is legally protected but it can also be ethically correct with respect to patients if it is private but still accessible data.

franciscatrigo10 — 2024-05-06 10:47:01 UTC